{"id": "article-57376_0", "title": "Thyroid Lymphoma -- Continuing Education Activity", "content": "Thyroid lymphoma is classified as either primary thyroid lymphoma or secondary thyroid lymphoma. Primary thyroid lymphoma affects the thyroid gland first, then spreads to the lymph nodes and other organs later. Secondary thyroid lymphoma affects lymph nodes and other organs first, then spreads to the thyroid later. Primary thyroid lymphomas are rare and further classified based on the underlying lymphoma subtype. These lymphomas are very sensitive to chemotherapy and radiation, which makes timely diagnosis a very crucial step. Timely diagnosis would enable instituting the appropriate local and systemic therapy early on with good outcomes. This activity reviews the etiology, presentation, evaluation, and management of primary thyroid lymphoma and the role of the interprofessional team in evaluating, diagnosing, and managing the condition.", "contents": "Thyroid Lymphoma -- Continuing Education Activity. Thyroid lymphoma is classified as either primary thyroid lymphoma or secondary thyroid lymphoma. Primary thyroid lymphoma affects the thyroid gland first, then spreads to the lymph nodes and other organs later. Secondary thyroid lymphoma affects lymph nodes and other organs first, then spreads to the thyroid later. Primary thyroid lymphomas are rare and further classified based on the underlying lymphoma subtype. These lymphomas are very sensitive to chemotherapy and radiation, which makes timely diagnosis a very crucial step. Timely diagnosis would enable instituting the appropriate local and systemic therapy early on with good outcomes. This activity reviews the etiology, presentation, evaluation, and management of primary thyroid lymphoma and the role of the interprofessional team in evaluating, diagnosing, and managing the condition."}
{"id": "article-57376_1", "title": "Thyroid Lymphoma -- Continuing Education Activity", "content": "Objectives: Differentiate between thyroid lymphoma and other thyroid cancers, ensuring accurate diagnosis and appropriate management. Implement\u00a0evidence-based strategies to implement timely and comprehensive evaluations once symptoms indicative of thyroid lymphoma are identified. Apply knowledge of optimal treatment approaches, including chemoimmunotherapy, chemotherapy, or radiation therapy, based on the specific subtype and stage of thyroid lymphoma. Collaborate among healthcare professionals, ensuring the involvement of a multidisciplinary team for comprehensive diagnosis and management. Access free multiple choice questions on this topic.", "contents": "Thyroid Lymphoma -- Continuing Education Activity. Objectives: Differentiate between thyroid lymphoma and other thyroid cancers, ensuring accurate diagnosis and appropriate management. Implement\u00a0evidence-based strategies to implement timely and comprehensive evaluations once symptoms indicative of thyroid lymphoma are identified. Apply knowledge of optimal treatment approaches, including chemoimmunotherapy, chemotherapy, or radiation therapy, based on the specific subtype and stage of thyroid lymphoma. Collaborate among healthcare professionals, ensuring the involvement of a multidisciplinary team for comprehensive diagnosis and management. Access free multiple choice questions on this topic."}
{"id": "article-57376_2", "title": "Thyroid Lymphoma -- Introduction", "content": "Thyroid lymphoma is classified as either primary thyroid lymphoma or secondary thyroid lymphoma. [1] Primary thyroid lymphoma\u00a0initially impacts\u00a0the thyroid gland,\u00a0with subsequent\u00a0spread to the lymph nodes and other organs occurring later. In contrast, secondary thyroid lymphoma\u00a0involves\u00a0lymph nodes and other organs first, followed by subsequent spread to the thyroid. This\u00a0activity exclusively concentrates\u00a0on primary thyroid lymphomas.", "contents": "Thyroid Lymphoma -- Introduction. Thyroid lymphoma is classified as either primary thyroid lymphoma or secondary thyroid lymphoma. [1] Primary thyroid lymphoma\u00a0initially impacts\u00a0the thyroid gland,\u00a0with subsequent\u00a0spread to the lymph nodes and other organs occurring later. In contrast, secondary thyroid lymphoma\u00a0involves\u00a0lymph nodes and other organs first, followed by subsequent spread to the thyroid. This\u00a0activity exclusively concentrates\u00a0on primary thyroid lymphomas."}
{"id": "article-57376_3", "title": "Thyroid Lymphoma -- Etiology", "content": "Primary thyroid lymphoma is uncommon, comprising less than\u00a05% of all thyroid malignancies and less than 3% of all extranodal lymphomas. [2] Primary thyroid lymphoma often\u00a0manifests\u00a0in individuals with preexisting Hashimoto (chronic autoimmune) thyroiditis, showing a significant\u00a0correlation with\u00a0previous autoimmune conditions. [3] The risk of developing primary thyroid lymphoma is\u00a0nearly 60 times higher in\u00a0individuals with thyroiditis compared to those without, typically\u00a0emerging 20 to 30 years after the initial diagnosis of thyroiditis. [4]", "contents": "Thyroid Lymphoma -- Etiology. Primary thyroid lymphoma is uncommon, comprising less than\u00a05% of all thyroid malignancies and less than 3% of all extranodal lymphomas. [2] Primary thyroid lymphoma often\u00a0manifests\u00a0in individuals with preexisting Hashimoto (chronic autoimmune) thyroiditis, showing a significant\u00a0correlation with\u00a0previous autoimmune conditions. [3] The risk of developing primary thyroid lymphoma is\u00a0nearly 60 times higher in\u00a0individuals with thyroiditis compared to those without, typically\u00a0emerging 20 to 30 years after the initial diagnosis of thyroiditis. [4]"}
{"id": "article-57376_4", "title": "Thyroid Lymphoma -- Epidemiology", "content": "The\u00a0yearly estimated incidence of thyroid lymphoma is\u00a0approximately 2 per 1 million individuals. [5] The occurrence and prevalence of primary thyroid lymphoma\u00a0are\u00a0elevated in\u00a0regions with higher rates of thyroiditis. [6] This condition is more common in females, with a female-to-male predisposition ratio of approximately 4:1. The average diagnosis is around age 65. [7]", "contents": "Thyroid Lymphoma -- Epidemiology. The\u00a0yearly estimated incidence of thyroid lymphoma is\u00a0approximately 2 per 1 million individuals. [5] The occurrence and prevalence of primary thyroid lymphoma\u00a0are\u00a0elevated in\u00a0regions with higher rates of thyroiditis. [6] This condition is more common in females, with a female-to-male predisposition ratio of approximately 4:1. The average diagnosis is around age 65. [7]"}
{"id": "article-57376_5", "title": "Thyroid Lymphoma -- Pathophysiology", "content": "The chronic antigen stimulation and heightened proliferation of lymphocytes in autoimmune conditions like Hashimoto thyroiditis have been\u00a0suggested as\u00a0potential contributors to the\u00a0malignant transformation\u00a0leading to primary thyroid lymphoma. [5] Notably, there is no discernible association between\u00a0conditions like Grave disease, colloid goiter, exposure to ionizing radiation, or chromosomal abnormalities and the development of primary thyroid lymphoma. [8]", "contents": "Thyroid Lymphoma -- Pathophysiology. The chronic antigen stimulation and heightened proliferation of lymphocytes in autoimmune conditions like Hashimoto thyroiditis have been\u00a0suggested as\u00a0potential contributors to the\u00a0malignant transformation\u00a0leading to primary thyroid lymphoma. [5] Notably, there is no discernible association between\u00a0conditions like Grave disease, colloid goiter, exposure to ionizing radiation, or chromosomal abnormalities and the development of primary thyroid lymphoma. [8]"}
{"id": "article-57376_6", "title": "Thyroid Lymphoma -- Histopathology", "content": "Almost\u00a0all\u00a0instances\u00a0(98%) of primary thyroid lymphoma\u00a0belong to the category of B-cell, non-Hodgkin lymphomas. [7] Among B-cell lymphomas, the most\u00a0prevalent subtype is diffuse large B-cell lymphoma (DLBCL),\u00a0encompassing\u00a0approximately 60% to 70% of cases. Mucosa-associated lymphoid tissue (MALT) lymphoma/extranodal marginal zone lymphoma follows, constituting 10% to 23% of cases. Follicular lymphoma represents 10% of cases, followed by small lymphocytic lymphoma and chronic lymphocytic lymphoma at\u00a0around 3%. Mantle cell lymphoma constitutes less than 1% of cases.", "contents": "Thyroid Lymphoma -- Histopathology. Almost\u00a0all\u00a0instances\u00a0(98%) of primary thyroid lymphoma\u00a0belong to the category of B-cell, non-Hodgkin lymphomas. [7] Among B-cell lymphomas, the most\u00a0prevalent subtype is diffuse large B-cell lymphoma (DLBCL),\u00a0encompassing\u00a0approximately 60% to 70% of cases. Mucosa-associated lymphoid tissue (MALT) lymphoma/extranodal marginal zone lymphoma follows, constituting 10% to 23% of cases. Follicular lymphoma represents 10% of cases, followed by small lymphocytic lymphoma and chronic lymphocytic lymphoma at\u00a0around 3%. Mantle cell lymphoma constitutes less than 1% of cases."}
{"id": "article-57376_7", "title": "Thyroid Lymphoma -- Histopathology", "content": "Other rare histological types include Hodgkin lymphoma (2% of cases), T-cell lymphomas, and lymphoblastic lymphomas (<1% of cases). [5] [9] Intermittent T-cell primary thyroid lymphoma cases have been reported in regions endemic to human T-lymphotropic virus (HTLV) associated adult T-cell leukemia and lymphoma. [10] If untreated, indolent histologies like MALT lymphoma and extranodal marginal zone lymphoma can transform into aggressive histologies like DLBCL. Mixed histology, ie, DLBCL and MALT occurring together,\u00a0is observed in some cases. [5]", "contents": "Thyroid Lymphoma -- Histopathology. Other rare histological types include Hodgkin lymphoma (2% of cases), T-cell lymphomas, and lymphoblastic lymphomas (<1% of cases). [5] [9] Intermittent T-cell primary thyroid lymphoma cases have been reported in regions endemic to human T-lymphotropic virus (HTLV) associated adult T-cell leukemia and lymphoma. [10] If untreated, indolent histologies like MALT lymphoma and extranodal marginal zone lymphoma can transform into aggressive histologies like DLBCL. Mixed histology, ie, DLBCL and MALT occurring together,\u00a0is observed in some cases. [5]"}
{"id": "article-57376_8", "title": "Thyroid Lymphoma -- History and Physical", "content": "The aggressiveness of clinical presentation depends on histology, with DLBCL\u00a0displaying a more aggressive behavior than indolent lymphomas like MALT lymphoma or follicular lymphomas. The duration of symptoms before diagnosis can range\u00a0widely, ranging from a few days to a few years, with a\u00a0notably shorter duration reported in DLBCL. [11]", "contents": "Thyroid Lymphoma -- History and Physical. The aggressiveness of clinical presentation depends on histology, with DLBCL\u00a0displaying a more aggressive behavior than indolent lymphomas like MALT lymphoma or follicular lymphomas. The duration of symptoms before diagnosis can range\u00a0widely, ranging from a few days to a few years, with a\u00a0notably shorter duration reported in DLBCL. [11]"}
{"id": "article-57376_9", "title": "Thyroid Lymphoma -- History and Physical", "content": "The predominant local symptom is a rapidly enlarging thyroid gland (goiter), accompanied by obstructive symptoms\u00a0resulting from the\u00a0enlarged gland. [7] [12] These obstructive symptoms include dyspnea, stridor due to tracheal compression, dysphagia due to esophageal compression, neck pain, facial edema due to compression of neck veins and the superior vena cava, and hoarseness of voice due to recurrent laryngeal nerve compression.", "contents": "Thyroid Lymphoma -- History and Physical. The predominant local symptom is a rapidly enlarging thyroid gland (goiter), accompanied by obstructive symptoms\u00a0resulting from the\u00a0enlarged gland. [7] [12] These obstructive symptoms include dyspnea, stridor due to tracheal compression, dysphagia due to esophageal compression, neck pain, facial edema due to compression of neck veins and the superior vena cava, and hoarseness of voice due to recurrent laryngeal nerve compression."}
{"id": "article-57376_10", "title": "Thyroid Lymphoma -- History and Physical", "content": "The systemic symptoms\u00a0encompass B-symptoms of lymphoma, such as fever, night sweats, and weight loss, as well as symptoms of hypothyroidism, including fatigue, cold intolerance, constipation, dry skin/hair, hoarse voice, and menstrual irregularities. Hypothyroidism in these patients is commonly due to Hashimoto thyroiditis and, infrequently, to diffuse thyroid gland infiltration by the lymphoma. Rarely, some patients may\u00a0exhibit symptoms of hyperthyroidism due to the destruction of the thyroid follicles by the lymphoma. [13] Patients\u00a0with Hashimoto thyroiditis\u00a0undergoing\u00a0thyroid hormone replacement are expected to\u00a0maintain\u00a0euthyroid status.", "contents": "Thyroid Lymphoma -- History and Physical. The systemic symptoms\u00a0encompass B-symptoms of lymphoma, such as fever, night sweats, and weight loss, as well as symptoms of hypothyroidism, including fatigue, cold intolerance, constipation, dry skin/hair, hoarse voice, and menstrual irregularities. Hypothyroidism in these patients is commonly due to Hashimoto thyroiditis and, infrequently, to diffuse thyroid gland infiltration by the lymphoma. Rarely, some patients may\u00a0exhibit symptoms of hyperthyroidism due to the destruction of the thyroid follicles by the lymphoma. [13] Patients\u00a0with Hashimoto thyroiditis\u00a0undergoing\u00a0thyroid hormone replacement are expected to\u00a0maintain\u00a0euthyroid status."}
{"id": "article-57376_11", "title": "Thyroid Lymphoma -- History and Physical", "content": "Physical examination\u00a0typically reveals a firm to hard, diffusely enlarged, and immobile thyroid gland, accompanied by cervical or supraclavicular lymphadenopathy. [12] Rarely, some patients may\u00a0present with a large\u00a0distinct nodule instead of diffuse thyroid enlargement.", "contents": "Thyroid Lymphoma -- History and Physical. Physical examination\u00a0typically reveals a firm to hard, diffusely enlarged, and immobile thyroid gland, accompanied by cervical or supraclavicular lymphadenopathy. [12] Rarely, some patients may\u00a0present with a large\u00a0distinct nodule instead of diffuse thyroid enlargement."}
{"id": "article-57376_12", "title": "Thyroid Lymphoma -- Evaluation", "content": "The workup for thyroid lymphoma should encompass the following:", "contents": "Thyroid Lymphoma -- Evaluation. The workup for thyroid lymphoma should encompass the following:"}
{"id": "article-57376_13", "title": "Thyroid Lymphoma -- Evaluation -- Laboratory Evaluation", "content": "There is no specific or pathognomic laboratory finding in thyroid lymphomas. Laboratory findings\u00a0associated with hypothyroidism (elevated thyroid stimulating hormone [TSH], low T3, and T4) and Hashimoto thyroiditis (elevated antithyroglobulin or antithyroid peroxidase antibodies)\u00a0are common. [14] Rarely, laboratory findings\u00a0indicate hyperthyroidism, characterized by low TSH and elevated T3 and T4 levels. If patients with Hashimoto thyroiditis are undergoing\u00a0thyroid hormone replacement, laboratory findings of euthyroidism (normal TSH, T3, and T4) are expected.", "contents": "Thyroid Lymphoma -- Evaluation -- Laboratory Evaluation. There is no specific or pathognomic laboratory finding in thyroid lymphomas. Laboratory findings\u00a0associated with hypothyroidism (elevated thyroid stimulating hormone [TSH], low T3, and T4) and Hashimoto thyroiditis (elevated antithyroglobulin or antithyroid peroxidase antibodies)\u00a0are common. [14] Rarely, laboratory findings\u00a0indicate hyperthyroidism, characterized by low TSH and elevated T3 and T4 levels. If patients with Hashimoto thyroiditis are undergoing\u00a0thyroid hormone replacement, laboratory findings of euthyroidism (normal TSH, T3, and T4) are expected."}
{"id": "article-57376_14", "title": "Thyroid Lymphoma -- Evaluation -- Imaging", "content": "Thyroid ultrasound is the recommended initial imaging modality. Although there are no specific findings, characteristic features\u00a0within\u00a01 of the\u00a03 patterns (nodular, diffuse, or mixed) of thyroid appearance can suggest primary thyroid lymphoma. Thyroid ultrasound often\u00a0reveals\u00a0enhanced posterior echoes, multiple hypoechogenic areas resembling pseudocysts, and increased vascularity. [5] [15] In a prospective study, 74 of 165 patients (47.9%) suspected of having malignant thyroid lymphoma based on ultrasound findings had pathologically confirmed lymphoma. [16]", "contents": "Thyroid Lymphoma -- Evaluation -- Imaging. Thyroid ultrasound is the recommended initial imaging modality. Although there are no specific findings, characteristic features\u00a0within\u00a01 of the\u00a03 patterns (nodular, diffuse, or mixed) of thyroid appearance can suggest primary thyroid lymphoma. Thyroid ultrasound often\u00a0reveals\u00a0enhanced posterior echoes, multiple hypoechogenic areas resembling pseudocysts, and increased vascularity. [5] [15] In a prospective study, 74 of 165 patients (47.9%) suspected of having malignant thyroid lymphoma based on ultrasound findings had pathologically confirmed lymphoma. [16]"}
{"id": "article-57376_15", "title": "Thyroid Lymphoma -- Evaluation -- Imaging", "content": "To determine the extent of disease,\u00a0including extrathyroidal spread, tracheal invasion, and lymph node involvement, computed tomography (CT) or magnetic resonance imaging (MRI) are more useful than ultrasound. Other imaging studies like 18-fluorodeoxyglucose (FDG) positron emission tomography (PET) show increased uptake throughout the thyroid gland. PET scans\u00a0offer superior diagnostic accuracy in lymphoma for staging and assessing response to treatment but\u00a0are\u00a0less useful for the initial diagnosis as they cannot differentiate thyroid lymphoma from other conditions like Hashimoto thyroiditis. [17]", "contents": "Thyroid Lymphoma -- Evaluation -- Imaging. To determine the extent of disease,\u00a0including extrathyroidal spread, tracheal invasion, and lymph node involvement, computed tomography (CT) or magnetic resonance imaging (MRI) are more useful than ultrasound. Other imaging studies like 18-fluorodeoxyglucose (FDG) positron emission tomography (PET) show increased uptake throughout the thyroid gland. PET scans\u00a0offer superior diagnostic accuracy in lymphoma for staging and assessing response to treatment but\u00a0are\u00a0less useful for the initial diagnosis as they cannot differentiate thyroid lymphoma from other conditions like Hashimoto thyroiditis. [17]"}
{"id": "article-57376_16", "title": "Thyroid Lymphoma -- Evaluation -- Pathology", "content": "The definitive diagnosis of primary thyroid lymphoma is\u00a0established through histopathological analysis of tissue. Fine needle aspiration (FNA) is the initial diagnostic procedure for thyroid tissue sampling. [2] [15] FNA alone has low sensitivity,\u00a0diagnosing only 50% to 80% of cases depending on the study, and is more likely to be diagnostic in patients with a large lymphoma burden. [2] [18] Core biopsy is more sensitive than FNA, providing larger tissue samples and preserving tissue architecture, facilitating the differentiation between thyroiditis and lymphoma, and identifying the lymphoma subtype.\u00a0Although the sensitivity of FNA has improved with newer adjuncts like flow cytometry and immunohistochemical staining that help establish the monoclonality of lymphocytes, a core biopsy is still suggested for definitive diagnosis when primary thyroid lymphoma is suspected. [15] [19] Open surgical biopsy is\u00a0reserved for cases where less invasive techniques (like FNA or core needle biopsy)\u00a0cannot definitively establish the diagnosis or identify the\u00a0subtype of primary thyroid lymphoma. [2]", "contents": "Thyroid Lymphoma -- Evaluation -- Pathology. The definitive diagnosis of primary thyroid lymphoma is\u00a0established through histopathological analysis of tissue. Fine needle aspiration (FNA) is the initial diagnostic procedure for thyroid tissue sampling. [2] [15] FNA alone has low sensitivity,\u00a0diagnosing only 50% to 80% of cases depending on the study, and is more likely to be diagnostic in patients with a large lymphoma burden. [2] [18] Core biopsy is more sensitive than FNA, providing larger tissue samples and preserving tissue architecture, facilitating the differentiation between thyroiditis and lymphoma, and identifying the lymphoma subtype.\u00a0Although the sensitivity of FNA has improved with newer adjuncts like flow cytometry and immunohistochemical staining that help establish the monoclonality of lymphocytes, a core biopsy is still suggested for definitive diagnosis when primary thyroid lymphoma is suspected. [15] [19] Open surgical biopsy is\u00a0reserved for cases where less invasive techniques (like FNA or core needle biopsy)\u00a0cannot definitively establish the diagnosis or identify the\u00a0subtype of primary thyroid lymphoma. [2]"}
{"id": "article-57376_17", "title": "Thyroid Lymphoma -- Treatment / Management", "content": "The management\u00a0of primary thyroid lymphoma depends on the histological subtype and staging of the tumor.\u00a0Given\u00a0the rarity of primary thyroid lymphoma, large prospective randomized trials for optimal management are limited. Treatment recommendations primarily derive\u00a0from extrapolation based on\u00a0prospective, randomized studies in non-Hodgkin lymphomas.", "contents": "Thyroid Lymphoma -- Treatment / Management. The management\u00a0of primary thyroid lymphoma depends on the histological subtype and staging of the tumor.\u00a0Given\u00a0the rarity of primary thyroid lymphoma, large prospective randomized trials for optimal management are limited. Treatment recommendations primarily derive\u00a0from extrapolation based on\u00a0prospective, randomized studies in non-Hodgkin lymphomas."}
{"id": "article-57376_18", "title": "Thyroid Lymphoma -- Treatment / Management", "content": "For DLBCL histology, combined modality treatment\u00a0involving chemotherapy and radiotherapy is preferred for limited-stage (IE or IIE) DLBCL, as it is associated with a higher 5-year failure-free survival rate than chemotherapy alone. [20] For advanced stage (IIIE or IV) DLBCL, the first-line treatment involves rituximab (a monoclonal antibody selectively binding the\u00a0CD20 antigen on the pre-B and mature B lymphocytes) in combination with chemotherapy (R-CHOP:\u00a0rituximab in combination with cyclophosphamide, doxorubicin, vincristine, prednisolone).", "contents": "Thyroid Lymphoma -- Treatment / Management. For DLBCL histology, combined modality treatment\u00a0involving chemotherapy and radiotherapy is preferred for limited-stage (IE or IIE) DLBCL, as it is associated with a higher 5-year failure-free survival rate than chemotherapy alone. [20] For advanced stage (IIIE or IV) DLBCL, the first-line treatment involves rituximab (a monoclonal antibody selectively binding the\u00a0CD20 antigen on the pre-B and mature B lymphocytes) in combination with chemotherapy (R-CHOP:\u00a0rituximab in combination with cyclophosphamide, doxorubicin, vincristine, prednisolone)."}
{"id": "article-57376_19", "title": "Thyroid Lymphoma -- Treatment / Management", "content": "For other histologies like MALT lymphoma and follicular lymphoma, treatment options for limited-stage (IE or IIE) include radiotherapy alone or combined modality treatment with\u00a0chemoimmunotherapy using rituximab. For advanced-stage (IIIE or IV) indolent varieties of thyroid lymphoma, rituximab alone or in combination with chemotherapy stands as the first-line treatment option. [20] [21]", "contents": "Thyroid Lymphoma -- Treatment / Management. For other histologies like MALT lymphoma and follicular lymphoma, treatment options for limited-stage (IE or IIE) include radiotherapy alone or combined modality treatment with\u00a0chemoimmunotherapy using rituximab. For advanced-stage (IIIE or IV) indolent varieties of thyroid lymphoma, rituximab alone or in combination with chemotherapy stands as the first-line treatment option. [20] [21]"}
{"id": "article-57376_20", "title": "Thyroid Lymphoma -- Treatment / Management", "content": "Surgery is generally not recommended for the treatment of primary thyroid lymphoma. It holds no role\u00a0beyond diagnostic biopsy due to potential surgical risks and\u00a0the absence of additional benefits compared to chemoradiation therapy. [2] Obstructive symptoms usually improve within days of chemotherapy (R-CHOP) initiation due to the steroid in the regimen.\u00a0The rapid alleviation of symptoms allows for the\u00a0safe and successful medical management of severe airway compromise due to tracheal compression, often avoiding the need for tracheostomy or thyroidectomy. [2]", "contents": "Thyroid Lymphoma -- Treatment / Management. Surgery is generally not recommended for the treatment of primary thyroid lymphoma. It holds no role\u00a0beyond diagnostic biopsy due to potential surgical risks and\u00a0the absence of additional benefits compared to chemoradiation therapy. [2] Obstructive symptoms usually improve within days of chemotherapy (R-CHOP) initiation due to the steroid in the regimen.\u00a0The rapid alleviation of symptoms allows for the\u00a0safe and successful medical management of severe airway compromise due to tracheal compression, often avoiding the need for tracheostomy or thyroidectomy. [2]"}
{"id": "article-57376_21", "title": "Thyroid Lymphoma -- Treatment / Management", "content": "The management strategy for hypothyroidism symptoms, whether arising from Hashimoto thyroiditis, diffuse thyroid gland infiltration by the lymphoma, or radiation-associated hypothyroidism, involves thyroid hormone replacement. A study at the Mayo Clinic demonstrated that diagnostic biopsy followed by definitive chemotherapy alone was more effective in complete remission rates than undergoing surgical debulking followed by adjuvant therapies. [22]", "contents": "Thyroid Lymphoma -- Treatment / Management. The management strategy for hypothyroidism symptoms, whether arising from Hashimoto thyroiditis, diffuse thyroid gland infiltration by the lymphoma, or radiation-associated hypothyroidism, involves thyroid hormone replacement. A study at the Mayo Clinic demonstrated that diagnostic biopsy followed by definitive chemotherapy alone was more effective in complete remission rates than undergoing surgical debulking followed by adjuvant therapies. [22]"}
{"id": "article-57376_22", "title": "Thyroid Lymphoma -- Treatment / Management", "content": "Treatment failures, categorized as refractory lymphoma (no response to initial treatment or reoccurrence shortly after completing treatment) or relapsed lymphoma (responds to treatment and\u00a0enters\u00a0remission but recurs after a period), can occur. Subsequent treatment options for refractory and relapsed cases\u00a0vary, contingent on histology and time taken for relapse following initial treatment. These options are primarily\u00a0informed by evidence from\u00a0non-Hodgkin lymphoma trials and studies.", "contents": "Thyroid Lymphoma -- Treatment / Management. Treatment failures, categorized as refractory lymphoma (no response to initial treatment or reoccurrence shortly after completing treatment) or relapsed lymphoma (responds to treatment and\u00a0enters\u00a0remission but recurs after a period), can occur. Subsequent treatment options for refractory and relapsed cases\u00a0vary, contingent on histology and time taken for relapse following initial treatment. These options are primarily\u00a0informed by evidence from\u00a0non-Hodgkin lymphoma trials and studies."}
{"id": "article-57376_23", "title": "Thyroid Lymphoma -- Differential Diagnosis", "content": "The\u00a0primary differential diagnosis for primary thyroid lymphoma is anaplastic thyroid carcinoma, given its clinical resemblance characterized by the presentation of a rapidly growing thyroid mass that is firm and fixed to surrounding structures. Other differentials include primary thyroid carcinomas like papillary thyroid carcinoma, follicular thyroid carcinoma, and medullary thyroid carcinoma, and benign conditions like simple colloid goiter and benign thyroid nodules.", "contents": "Thyroid Lymphoma -- Differential Diagnosis. The\u00a0primary differential diagnosis for primary thyroid lymphoma is anaplastic thyroid carcinoma, given its clinical resemblance characterized by the presentation of a rapidly growing thyroid mass that is firm and fixed to surrounding structures. Other differentials include primary thyroid carcinomas like papillary thyroid carcinoma, follicular thyroid carcinoma, and medullary thyroid carcinoma, and benign conditions like simple colloid goiter and benign thyroid nodules."}
{"id": "article-57376_24", "title": "Thyroid Lymphoma -- Differential Diagnosis", "content": "Despite its rarity, primary thyroid lymphoma should always be considered in the list of potential diagnoses for any rapidly growing thyroid nodules or goiter. Early diagnosis and appropriate management\u00a0play a crucial role in impacting the prognosis.", "contents": "Thyroid Lymphoma -- Differential Diagnosis. Despite its rarity, primary thyroid lymphoma should always be considered in the list of potential diagnoses for any rapidly growing thyroid nodules or goiter. Early diagnosis and appropriate management\u00a0play a crucial role in impacting the prognosis."}
{"id": "article-57376_25", "title": "Thyroid Lymphoma -- Staging", "content": "The Lugano staging system or modified Ann Arbor staging classification determines the staging of primary thyroid lymphomas. [23] Imaging for lymphoma staging includes imaging the whole body with either FDG PET/ CT for FDG avid lymphomas or CT\u00a0scans (of the head, neck, chest, abdomen, and pelvis)\u00a0for FDG non-avid lymphomas like MALT lymphoma and small lymphocytic lymphoma. Almost 80% of patients\u00a0present with limited disease (stage IE: thyroid only or IIE: thyroid with regional lymph nodes involvement), while about 20% of patients have advanced disease (stage IIIE: thyroid with lymph nodes and organs involvement on both sides of the diaphragm or stage IV: disseminated lymphoma). [7] [24] Accurate staging at the time of presentation is crucial for assessing prognosis, determining the appropriate treatment, and evaluating treatment response.", "contents": "Thyroid Lymphoma -- Staging. The Lugano staging system or modified Ann Arbor staging classification determines the staging of primary thyroid lymphomas. [23] Imaging for lymphoma staging includes imaging the whole body with either FDG PET/ CT for FDG avid lymphomas or CT\u00a0scans (of the head, neck, chest, abdomen, and pelvis)\u00a0for FDG non-avid lymphomas like MALT lymphoma and small lymphocytic lymphoma. Almost 80% of patients\u00a0present with limited disease (stage IE: thyroid only or IIE: thyroid with regional lymph nodes involvement), while about 20% of patients have advanced disease (stage IIIE: thyroid with lymph nodes and organs involvement on both sides of the diaphragm or stage IV: disseminated lymphoma). [7] [24] Accurate staging at the time of presentation is crucial for assessing prognosis, determining the appropriate treatment, and evaluating treatment response."}
{"id": "article-57376_26", "title": "Thyroid Lymphoma -- Prognosis", "content": "The prognosis of primary thyroid lymphoma depends on various factors such as histology, tumor burden, stage, age, performance status, treatment modality, and type.\u00a0Histology-specific disease-free survival rates from the Surveillance Epidemiology and End Result (SEER) database estimate a 5-year disease-free survival rate of 96% for MALT lymphoma, 87% for follicular lymphoma, 86% for small lymphocytic lymphoma, and 75% for DLBCL. [2] Histology-specific overall survival rates from the UK lymphoma treatment center experience estimate a 5-year survival rate of 75% for indolent B-cell lymphoma not otherwise specified, 62% for MALT lymphoma, and 45% for DLBCL, with a median overall survival of all histological subtypes\u00a0being 5.7 years. [25]", "contents": "Thyroid Lymphoma -- Prognosis. The prognosis of primary thyroid lymphoma depends on various factors such as histology, tumor burden, stage, age, performance status, treatment modality, and type.\u00a0Histology-specific disease-free survival rates from the Surveillance Epidemiology and End Result (SEER) database estimate a 5-year disease-free survival rate of 96% for MALT lymphoma, 87% for follicular lymphoma, 86% for small lymphocytic lymphoma, and 75% for DLBCL. [2] Histology-specific overall survival rates from the UK lymphoma treatment center experience estimate a 5-year survival rate of 75% for indolent B-cell lymphoma not otherwise specified, 62% for MALT lymphoma, and 45% for DLBCL, with a median overall survival of all histological subtypes\u00a0being 5.7 years. [25]"}
{"id": "article-57376_27", "title": "Thyroid Lymphoma -- Complications", "content": "Complications\u00a0arising from\u00a0thyroid lymphoma include life-threatening\u00a0issues like airway compromise due to tracheal compression, superior vena cava syndrome due to superior vena cava compression, and dysphagia due to esophageal compression. Additionally, complications\u00a0stemming\u00a0from lymphoma treatment include radiation-associated hypothyroidism, radiation-associated malignancies of the thyroid or other exposed organs, chemotherapy-related side effects like peripheral neuropathy due to vincristine, congestive heart failure due to doxorubicin, conditions such as hemorrhagic cystitis or bladder cancer due to cyclophosphamide.", "contents": "Thyroid Lymphoma -- Complications. Complications\u00a0arising from\u00a0thyroid lymphoma include life-threatening\u00a0issues like airway compromise due to tracheal compression, superior vena cava syndrome due to superior vena cava compression, and dysphagia due to esophageal compression. Additionally, complications\u00a0stemming\u00a0from lymphoma treatment include radiation-associated hypothyroidism, radiation-associated malignancies of the thyroid or other exposed organs, chemotherapy-related side effects like peripheral neuropathy due to vincristine, congestive heart failure due to doxorubicin, conditions such as hemorrhagic cystitis or bladder cancer due to cyclophosphamide."}
{"id": "article-57376_28", "title": "Thyroid Lymphoma -- Deterrence and Patient Education", "content": "Lymphoma is characterized by the uncontrolled growth of\u00a0cohesive cancerous lymphatic cells. In thyroid lymphoma, these\u00a0aberrant lymphoid cells\u00a0cause the\u00a0thyroid\u00a0gland\u00a0to enlarge, leading to various symptoms associated with thyroid dysfunction and gland enlargement. Patients may also experience symptoms like fever, night sweats, and weight loss due to the lymphoma itself. Multiple laboratory investigations, imaging, and thyroid gland biopsy are needed to establish the diagnosis and stage of the lymphoma.", "contents": "Thyroid Lymphoma -- Deterrence and Patient Education. Lymphoma is characterized by the uncontrolled growth of\u00a0cohesive cancerous lymphatic cells. In thyroid lymphoma, these\u00a0aberrant lymphoid cells\u00a0cause the\u00a0thyroid\u00a0gland\u00a0to enlarge, leading to various symptoms associated with thyroid dysfunction and gland enlargement. Patients may also experience symptoms like fever, night sweats, and weight loss due to the lymphoma itself. Multiple laboratory investigations, imaging, and thyroid gland biopsy are needed to establish the diagnosis and stage of the lymphoma."}
{"id": "article-57376_29", "title": "Thyroid Lymphoma -- Deterrence and Patient Education", "content": "Treatment options are diverse and depend on the specific subtype and stage of the lymphoma, typically involving a multidisciplinary team of specialists such as medical oncologists, radiation oncologists, oncology pharmacists, and oncology nurses. The prognosis is influenced by factors like age, functional status, tumor type, and stage, but overall, primary thyroid lymphoma\u00a0demonstrates an excellent prognosis\u00a0when promptly identified and treated.", "contents": "Thyroid Lymphoma -- Deterrence and Patient Education. Treatment options are diverse and depend on the specific subtype and stage of the lymphoma, typically involving a multidisciplinary team of specialists such as medical oncologists, radiation oncologists, oncology pharmacists, and oncology nurses. The prognosis is influenced by factors like age, functional status, tumor type, and stage, but overall, primary thyroid lymphoma\u00a0demonstrates an excellent prognosis\u00a0when promptly identified and treated."}
{"id": "article-57376_30", "title": "Thyroid Lymphoma -- Pearls and Other Issues", "content": "Key facts to\u00a0keep in mind about thyroid lymphoma are as follows: Early recognition of thyroid lymphoma is crucial for optimal outcomes. Proper staging using the Lugano system guides treatment decisions. Prognosis varies with factors such as histology, stage, and treatment modality. A multidisciplinary approach involving medical oncologists, radiation oncologists, and otolaryngologists is essential.", "contents": "Thyroid Lymphoma -- Pearls and Other Issues. Key facts to\u00a0keep in mind about thyroid lymphoma are as follows: Early recognition of thyroid lymphoma is crucial for optimal outcomes. Proper staging using the Lugano system guides treatment decisions. Prognosis varies with factors such as histology, stage, and treatment modality. A multidisciplinary approach involving medical oncologists, radiation oncologists, and otolaryngologists is essential."}
{"id": "article-57376_31", "title": "Thyroid Lymphoma -- Enhancing Healthcare Team Outcomes", "content": "The management of primary thyroid lymphoma\u00a0necessitates\u00a0the involvement of an interprofessional team\u00a0comprising specialists from different departments, including a medical oncologist, radiation oncologist, otolaryngologist, primary care physician, endocrinologist, pathologist, and specialty care nurses. Typically, patients present to their primary care physician,\u00a0nurse practitioner, or endocrinologist with an enlarged neck mass and obstructive symptoms. The initial physician must maintain a high\u00a0level of suspicion for thyroid lymphoma and\u00a0collaborate with\u00a0the otolaryngologist and pathologist\u00a0to\u00a0establish a diagnosis\u00a0through a core biopsy of the thyroid.", "contents": "Thyroid Lymphoma -- Enhancing Healthcare Team Outcomes. The management of primary thyroid lymphoma\u00a0necessitates\u00a0the involvement of an interprofessional team\u00a0comprising specialists from different departments, including a medical oncologist, radiation oncologist, otolaryngologist, primary care physician, endocrinologist, pathologist, and specialty care nurses. Typically, patients present to their primary care physician,\u00a0nurse practitioner, or endocrinologist with an enlarged neck mass and obstructive symptoms. The initial physician must maintain a high\u00a0level of suspicion for thyroid lymphoma and\u00a0collaborate with\u00a0the otolaryngologist and pathologist\u00a0to\u00a0establish a diagnosis\u00a0through a core biopsy of the thyroid."}
{"id": "article-57376_32", "title": "Thyroid Lymphoma -- Enhancing Healthcare Team Outcomes", "content": "Once the diagnosis is confirmed, the medical oncologist, radiation oncologist, and endocrinologist should all be actively involved, and additional workup and treatment should commence immediately. Primary thyroid lymphoma\u00a0demonstrates a good prognosis if the patient promptly receives well-coordinated care from all the specialists. Diagnosing and managing\u00a0thyroid lymphoma require an interprofessional team approach, including physicians, specialists, specialty-trained nurses, and pharmacists collaborating across disciplines to achieve optimal patient outcomes. Oncology nurses\u00a0play a vital role in administering chemotherapy, educating patients and their families, and\u00a0providing the team updates on the patient's status. Pharmacists\u00a0contribute by reviewing\u00a0medications for dose and drug-drug interactions and participating in education.", "contents": "Thyroid Lymphoma -- Enhancing Healthcare Team Outcomes. Once the diagnosis is confirmed, the medical oncologist, radiation oncologist, and endocrinologist should all be actively involved, and additional workup and treatment should commence immediately. Primary thyroid lymphoma\u00a0demonstrates a good prognosis if the patient promptly receives well-coordinated care from all the specialists. Diagnosing and managing\u00a0thyroid lymphoma require an interprofessional team approach, including physicians, specialists, specialty-trained nurses, and pharmacists collaborating across disciplines to achieve optimal patient outcomes. Oncology nurses\u00a0play a vital role in administering chemotherapy, educating patients and their families, and\u00a0providing the team updates on the patient's status. Pharmacists\u00a0contribute by reviewing\u00a0medications for dose and drug-drug interactions and participating in education."}
{"id": "article-57376_33", "title": "Thyroid Lymphoma -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Thyroid Lymphoma -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}